Pelago Bioscience, based in Solna, is a leading specialized Contract Research Organization (CRO) that focuses on their revolutionary patented technology called CETSA®. With a wide range of bespoke projects and services, Pelago Bioscience is at the forefront of drug discovery. Their core technology, the Cellular Thermal Shift Assay (CETSA®), provides biologically relevant data that enables researchers to make informed decisions throughout the drug discovery process.

Unlike other solutions in the market, CETSA® allows for the assessment and quantification of target engagement under physiological conditions without modifying the compound or protein. Think of CETSA® as snapshots of true target engagement inside the cell, available whenever you need them. Whether it's confirming target engagement, understanding the mechanism of action, or conducting preclinical and clinical studies, Pelago Bioscience offers a range of customized services to support every stage of the drug discovery process.

Their expertise in biologically relevant assay systems, combined with their innovative technology, makes them the ideal research partner for unleashing the full potential of drug discovery. Find out more about their offerings and how CETSA® technology can accelerate your research by visiting their website